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The effect of demand for kidney transplantation, mea-
sured by end-stage renal disease (ESRD) incidence, on
access to transplantation is unknown. Using data from
the U.S. Census Bureau, Centers for Medicare & Med-
icaid Services (CMS) and the Organ Procurement and
Transplantation Network/Scientific Registry of Trans-
plant Recipients (OPTN/SRTR) from 2000 to 2008, we
performed donation service area (DSA) and patient-
level regression analyses to assess the effect of ESRD
incidence on access to the kidney waiting list and de-
ceased donor kidney transplantation. In DSAs, ESRD
incidence increased with greater density of high ESRD
incidence racial groups (African Americans and Native
Americans). Wait-list and transplant rates were rela-
tively lower in high ESRD incidence DSAs, but wait-list
rates were not drastically affected by ESRD incidence
at the patient level. Compared to low ESRD areas, high
ESRD areas were associated with lower adjusted trans-
plant rates among all ESRD patients (RR 0.68, 95% CI
0.66–0.70). Patients living in medium and high ESRD
areas had lower transplant rates from the waiting list
compared to those in low ESRD areas (medium: RR
0.68, 95% CI 0.66–0.69; high: RR 0.63, 95% CI 0.61–0.65).
Geographic variation in access to kidney transplant is
in part mediated by local ESRD incidence, which has
implications for allocation policy development.
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Introduction
End-stage renal disease (ESRD) is an extremely debilitating
condition and is associated with significant morbidity and
mortality. Hundreds of thousands of people in the United
States were receiving treatment for ESRD at the end of
2006, and the incidence and prevalence of the disease
continue to grow rapidly (1). For eligible patients, kidney
transplantation offers a durable treatment with a signifi-
cant survival benefit and better quality of life compared
to lifetime dialysis dependence (2,3). Increased recogni-
tion of the significant benefit of transplantation has led to
an expansion in the number of patients waiting for a kid-
ney. At the end of 2007, the number of kidney transplant
candidates on the waiting list totaled more than 76 000,
having grown by 86% over the preceding decade (4). With
growing demand for kidney transplantation in the United
States, the identification of patterns of variation in access
to kidney transplantation has attracted significant attention
in the literature. Several patient and provider-level factors
contribute to this variation including patient demographics
(5–7), patient race/ethnicity (8–10), the etiology of ESRD
(5), the degree of rurality where patients live (11,12) and
even ownership status of a patient’s dialysis center (13).
One of the most intriguing, and potentially remediable,
sources of variation in access to transplantation is the
effect of where ESRD patients live. Disparate access to
transplantation based on geography is an international phe-
nomena (14–16), and we have previously identified signif-
icant geographic variation in access to kidney transplan-
tation across the United States (17). In that study, we
demonstrated that the wait-listing, living donor and de-
ceased donor transplant rates varied substantially across
donation service areas (DSAs) and states. Many factors
could potentially contribute to geographic variation in ac-
cess to both the kidney transplant waiting list and success-
ful transplantation, but are not well understood. Figure 1
displays a conceptual model of factors that affect access
to kidney transplantation in a given geographic area. The
factors that will particularly affect access to transplant in-
clude differences in patient populations served, variation
in organ supply and differences in organ demand. Tremen-
dous variability in effective organ supply may be related
to differences in organ donation and conversion rates,
organ discard and other factors that organ procurement
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Figure 1: Organ demand affects access to kidney transplant independent of organ supply, provider behaviors and patient charac-
teristics. This conceptual model demonstrates the complex relationship between organ demand, organ supply, patient characteristics and
access to kidney transplantation. A patient’s individual characteristics including demographics, blood type, antibody status, attitude toward
transplantation and other factors are known to affect access to kidney transplantation. Organ demand, our primary variable of interest,
is defined as the incidence of ESRD in a given area, and represents a novel mechanism that may affect geographic variation in access
to kidney transplantation. The effective organ supply, which can be measured by the overall donation rate in a DSA, also independently
affects access to kidney transplantation. As shown, the organ supply is determined by several factors including the population death rate
in the area, and the performance and behaviors of OPOs and individual transplant programs. We theorized that organ demand, measured
by the incidence of ESRD in a given DSA would independently affect access to kidney transplantation, after accounting for differences in
the effective organ supply and patient characteristics.
organizations (OPOs) may affect, and has already led to
several policy initiatives (18). We have previously shown
that the density of transplant centers in a state or DSA
may affect access to kidney transplantation (17), but other
center practices related to the use of living donors, ECD
organs and organ acceptance protocols may also lead to
relative differences in organ supply in different areas. While
it has not been directly associated with alterations in do-
nation rates, the density of ESRD in the community, a
measure of the demand for organs, may have an effect
on organ supply by affecting how transplant programs and
OPOs behave. The baseline ESRD incidence and preva-
lence differs across ESRD geographic networks based on
population risk factors, and is growing at dramatically dif-
ferent rates across the country (1), which suggests that
geographic variation in demand for kidney transplantation
exists. For example, the ESRD rate within a DSA increases
with a greater density of African Americans in the popu-
lation, while the DSA-specific donation rate appears to be
insensitive of ESRD incidence (17).
Within this context, we sought to understand how the
density of ESRD in the population affects access to the
kidney transplant waiting list and successful kidney trans-
plantation, after accounting for differences in organ supply.
We hypothesized that higher ESRD incidence would be
associated with lower wait-list and transplant rates, even
after adjusting for the total donation rate. Additionally, we
sought to explore how organ supply varies with organ de-
mand within DSAs. In this article, we present the relation-
ship between access to transplant, organ supply and organ
demand using DSA-level and patient-level analyses.
Methods
Data sources
This article summarizes a special study using data from the U.S. Census
Bureau, Centers for Medicare & Medicaid Services (CMS) and the Organ
Procurement and Transplantation Network/Scientific Registry of Transplant
Recipients (OPTN/SRTR) from 2000 to 2008. The Population Estimates Pro-
gram, developed by the U.S. Census Bureau, prepares estimates of the
population by age, sex, race and Hispanic origin for the nation, states and
counties in the years between censuses (19). The CMS database includes
information on all ESRD patients in the United States. The OPTN/SRTR
database includes data on all wait-listed kidney transplant candidates, kid-
ney transplant recipients and kidney donors in the United States and
is described further in companion articles in this report. The CMS and
OPTN/SRTR data sources were supplemented with vital status information
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from the Social Security Death Master File (20). Data from the OPTN Donor
Referral database were used to assign the general population and dialysis
patients to DSAs (21).
Assignment of DSA was inferred by the county of residence for the general
and dialysis populations, and determined by the transplant center of registra-
tion for transplant candidates, center where the transplant was performed
for recipients, and the location of donation for organ donors. Classifications
of race were determined by each data source. Patients were assigned to
categories with low or high ESRD incidence. High incidence risk by race was
defined as a rate greater than 400 new ESRD patients per million general
population. African American and Native American patients were placed
in the high incidence category, while whites, Asians and Multiracial/Other
race patients were placed in the low incidence category.
DSA-level analyses
From 2000 to 2008, the count of the general population ranged from
282 171 936 to 304 059 724. Over this period, the total ESRD cases rose
to more than 107 000 cases per year. There were 243 662 waiting list
candidates, 83 691 kidney transplants and 62 622 donors over this period.
The average ESRD incidence rate per million population (PMP) for the pe-
riod was calculated by dividing the sum of the number of ESRD dialysis
patients by the sum of the general population and multiplying by one mil-
lion. Similarly, the average wait-list rate PMP, transplant rate PMP and donor
rate PMP were each calculated by dividing the sum of kidney waiting list
candidates, kidney transplant recipients and kidney donors, respectively, by
the sum of the general population. Wait-list and transplant rates per 100
ESRD population were calculated by dividing the sum of the waiting list and
transplant populations, respectively, by the sum of the ESRD population
and multiplying by 100. The transplant rate per 100 waiting list population
was similarly calculated by dividing the total transplant population into a
denominator comprised of the waiting list population. All rates were also
calculated for each DSA and for the low and high incidence populations.
For the DSA-level analyses, we evaluated the individual effects of organ
demand (DSA ESRD incidence PMP) and organ supply (DSA-specific donor
rate PMP) on three separate metrics of access to kidney transplantation
using simple linear regression. Those metrics served as dependent vari-
ables in separate models evaluating organ supply and demand and were
defined as (1) wait-list rates among the ESRD population, (2) transplant
rates among ESRD population and (3) transplant rates among wait-listed
candidates. We subsequently created a multivariable regression model to
estimate the transplant rate among wait-listed candidates by DSA, using
organ supply (DSA-specific donation rate PMP) and organ demand (DSA-
specific ESRD incidence PMP) as covariates. This model was additionally
stratified by high or low ESRD incidence race. We compared the partial R2
for both donation rate and ESRD incidence to determine which contributed
the most to the overall model variance.
Patient-level analyses
The ESRD population was created by assembling records of 662 785 ESRD
incident patients under the age of 75, who either began chronic dialysis
treatment or were placed on the OPTN kidney or kidney–pancreas waiting
list for a first transplant between 2000 and 2008. Patients placed on the
kidney waiting list prior to the start of dialysis were considered to have
ESRD beginning on the date of wait-listing. Patients who were added to
the waiting list on the same date that they underwent a living donor kid-
ney transplant were not counted as having been placed on the waiting list.
Patients who had already started dialysis, or were either wait-listed or trans-
planted prior to 2000, were excluded from the study population. Patients
living in a U.S. territory or with an unknown county of residence were also
excluded.
To estimate the effects of organ supply and demand on access to kidney
transplantation, DSAs were individually categorized into three groups based
on kidney donation rates, terciles, and ESRD incidence categories, respec-
tively. Low, medium and high were defined as a rate of less than 21.4,
21.4–25.7 and greater than 25.7 PMP, respectively. Similarly, low, medium
and high ESRD incidence groups were defined as an ESRD incidence rate
less than 300, 300–400 and greater than 400 PMP, respectively. These organ
supply and organ demand characteristics for each DSA were subsequently
assigned to each patient as described above. We also evaluated several
DSA-specific organ supply metrics that may be affected by variations in
organ demand in a DSA. These metrics included number of kidney trans-
plant programs, percent of kidney transplants from living donors, percent
of transplants from extended criteria donors (ECD), kidney discard rates,
donor conversion rates, organ acceptance rates and kidney donor risk index
(DRI). These metrics were measured individually for each DSA and grouped
into terciles as above. The correlation coefficients were determined from
the least squares method.
This study examined how ESRD incidence (low, medium, high) affected
access to kidney transplantation for individual patients, adjusted for pa-
tient race (low or high ESRD incidence) and donation rates in their DSA
(low, medium, high). Separate models were designed to estimate the
(1) wait-listing rates among ESRD patients, (2) deceased donor transplant
rates among wait-listed patients and (3) deceased donor transplant rates
among ESRD patients. These models were designed using multivariable
Cox proportional-hazards techniques, and were also adjusted for patient
demographics that are captured in the CMS and OPTN/SRTR databases.
Patients were followed from the onset of ESRD to the date of wait-listing,
from the onset of ESRD to the date of transplantation and from the date
of wait-listing to transplantation. The study end-date was December 31,
2008. Follow-up for wait-listing rates and deceased donor transplant rates
was censored at death, living donor transplant or end of study. Adjust-
ments for wait-listing rates and deceased donor transplant rates among
ESRD patients were patient age, race, ethnicity, sex, cause of ESRD, inci-
dence year (dialysis, wait-listing), comorbid conditions and insurance type.
Adjustments for analyses of deceased donor transplant rates among wait-
ing list patients were patient age at wait-listing, race, ethnicity, sex, ESRD
cause, wait-listing year, comorbid conditions at wait-listing, insurance type
at wait-listing, blood type, panel reactive antibody (PRA) at wait-listing and
candidate human leukocyte antigens (HLA). The models provided adjusted
relative rates of wait-listing and transplantation, based on the patient’s DSA
organ supply and demand characteristics. Results are displayed as the rel-
ative rates for each level of DSA-specific incidence type compared to the
reference rate of 1.00 (low ESRD incidence DSA, low ESRD incidence race,
low donation DSA).
Results
Over the study period, several trends in the ESRD popula-
tion, kidney transplant waiting list and recipient populations
were notable (Figure 2). From 2000 to 2008, the number
of patients with ESRD increased by 16.2%, totaling more
than 107 000 in 2008. Approximately 70% of ESRD cases
were from low incident ESRD races, and nearly 30% were
attributed to the racial groups with high ESRD incidence
race. The kidney transplant waiting list grew at a faster rate
than the ESRD population, from 21 975 to 32 722 at the end
of 2008, representing a 48.9% expansion. In concert with
the increases in the ESRD and waiting list populations, the
transplant population grew by 30.1% over the study period,
with more than 10 000 transplants in 2008. The population
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Source: SRTR Special Analysis, August 2009
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Figure 2: Growing incident ESRD,
new kidney transplant waiting list,
kidney transplant and donor pop-
ulations, 2000–2008. Over an 8-year
period, the incidence of ESRD, num-
ber of waiting list registrations, kidney
transplants and donors has steadily
increased. These numbers have in-
creased in each subsequent year, vary-
ing by approximately 15–50% for each
metric.
of kidney donors grew by 33% as well, totaling more than
7800 donors at the end of 2008.
Table 1 displays racial differences in the general popula-
tion, ESRD incidence, kidney transplant wait-listing and
transplant rates. The high ESRD incidence group was com-
prised of 29% of the total population. Over the study pe-
riod, 347.1 ESRD cases occurred PMP overall. The high
incidence group had 743.4 cases PMP, and the low inci-
Table 1: ESRD, wait-list, transplant and donor rates overall and by
ESRD incidence, 2000–2008
High Low
incidence incidence
Population Total race1 race
Counts (n)
General2 2 637 315 005 362 339 559 2 274 975 446
ESRD 915 344 269 381 645 963
Wait-list 243 662 72 952 170 710
Transplant 83 691 26 147 57 544
Donor 62 622 9278 53 344
Per million general population
ESRD 347.1 743.4 283.9
Wait-list 92.4 201.3 75.0
Transplant 31.7 72.2 25.3
Donor 23.7 25.6 23.4
Per 100 ESRD population
Wait-list 26.6 27.1 26.4
Transplant 9.1 9.7 8.9
Per 100 waiting list population
Transplant 34.3 35.8 33.7
1High incidence races include African Americans and Native Amer-
icans.
2General population estimates from population division, U.S. Cen-
sus Bureau (release date: 5/14/2009).
dence group had 283.9 PMP. Despite the high prevalence
of ESRD in the cohort, there were an average of 92.4 wait-
ing list registrations PMP overall. High incidence groups
demonstrated higher wait-list rates versus low incidence
groups PMP. Transplant rates averaged PMP were simi-
lar between high and low incidence groups (high vs. low
incidence: 72.2 vs. 25.3 transplants PMP). Donation rates
were low, with an average of 23.7 donations PMP. Amongst
the ESRD population, wait-list rates and transplant rates
were slightly higher for the high incidence group compared
to the low incidence group. However, the high and low in-
cidence groups demonstrated similar transplant rates per
100 waiting list registrations (high vs. low incidence: 35.8
vs. 33.7).
Figure 3 displays the geographic variation in ESRD inci-
dence across the United States by DSA. Fourteen DSAs
had less than 300 cases of ESRD PMP, and were classified
as low. Thirty-one of the 57 DSAs were of medium ESRD
incidence (300–400 ESRD cases PMP), and were primarily
found in the eastern parts of the United States and most of
California. High ESRD incidence DSAs (>400 ESRD cases
PMP) (n = 12) were concentrated in two geographic ar-
eas: parts of the southern and middle Atlantic regions of
the county. The geographic variation in DSA-specific kid-
ney donation rates is shown in Figure 4. The distribution
of high donation DSAs geographically was highly variable,
but the majority were in the eastern United States. The
geographic variation in ESRD incidence and donation rate
was somewhat discordant. While most high or moderate
ESRD areas had simultaneously high or moderate donation
rates, two areas demonstrated high ESRD concentration,
but low donation rates: the state of Tennessee and north-
eastern Ohio. Many areas of the country with low ESRD
incidence had moderate to high donation rates.
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Figure 3: Geographic variation in
ESRD incidence rates by DSA. The
majority of the United States geo-
graphically has demonstrated a low or
medium ESRD incidence over the 8-
year cohort. High ESRD incidence is
concentrated in a few areas of the
country, including parts of the south-
eastern United States, the middle At-
lantic region and contiguous areas in
the Midwestern United States.
The six panels in Figure 5 display the complex relation-
ship between access to transplantation, organ supply and
organ demand in a DSA-level analysis. Organ supply, as
defined by donation incidence PMP, was significantly asso-
ciated with the transplant rate among 100 ESRD patients.
Donation rates were not significantly associated with wait-
listing rates or transplant rates from the waiting list. With
regards to organ demand, defined as the ESRD incidence
PMP, we noted impaired access to kidney transplantation
among ESRD patients with increasing concentration of
ESRD within a DSA. Wait-list rates among ESRD patients
within a DSA declined slightly with increasing incidence,
and this trend was also noted in transplant rates from the
waiting list. These latter trends were not significant, how-
ever. Organ demand and supply significantly affected over-
all transplant rates from the ESRD population at the DSA
level.
Using multivariable regression, we assessed the effect of
the donation rate and ESRD incidence within a DSA on its
transplant rate among wait-listed candidates for both high
and low incidence groups. We found that ESRD incidence
within a DSA explained as much of the variance as did the
donation rate in predicting transplant rate (partial R2: all
Figure 4: Geographic variation in
kidney donation rates by DSA. Com-
pared to the geographic variation seen
in ESRD incidence (Figure 3), the
United States was more heteroge-
neous with regards to donation rates.
The northeastern and western U.S.
states, with the exception of parts
of Nevada and contiguous areas, had
the lowest donation rates per million
population (PMP). Several areas in the
southeast, middle Atlantic and Mid-
west had higher donation rates.
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Figure 5: Donor organ supply and demand for kidney transplantation. These panels demonstrate six DSA-level models used to
evaluate the effect of organ supply (DSA-specific donation rate) and organ demand (DSA-specific ESRD incidence) on three different
metrics of access to kidney transplantation: wait-listing rates among ESRD patients (A, B); transplant rate among new ESRD patients
(C, D); and transplant rates among wait-listed candidates (E, F). Panel (A) Wait-listing rates among ESRD patients increased slightly, but
not significantly, with donation rates. Panel (B) Rates declined with increasing ESRD incidence, but not significantly. Panels (C) and (D)
indicate that organ supply was positively correlated with kidney transplant rates among ESRD patients, while increasing ESRD incidence
was associated with lower transplant rates. Panels (E) and (F), however, indicate that neither DSA-specific organ supply nor demand was
significantly associated with DSA-specific transplant rates from the waiting list.
races: ESRD incidence 0.08, donation rate 0.08) (data not
shown). By high incidence or low incidence race in sub-
group analyses, ESRD incidence continued to account for
a significant proportion of the variance in predictive models
for transplant rate within a DSA (partial R2: low incidence
race: ESRD incidence, 0.08; donation rate, 0.11; high in-
cidence race: ESRD incidence, 0.06; donation rate 0.08)
(data not shown). The univariate and multivariate DSA-level
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Table 2: Relative rate1 of transplant among ESRD patients by subgroup, 2000–2008
Measure N % RR1 p-Value 95% CI
OPO-donation rate
Low 226 405 34 1.00 Ref
Medium 241 950 37 1.33 <.0001 (1.30, 1.36)
High 194 430 29 1.63 <.0001 (1.60, 1.67)
All 662 785 100
Race—ESRD incidence
Low 438 342 66 1.00 Ref
High 224 443 34 0.56 <.0001 (0.55, 0.58)
OPO—ESRD incidence
Low 104 745 16 1.00 Ref
Medium 426 746 64 0.70 <.0001 (0.69, 0.72)
High 131 294 20 0.68 <.0001 (0.66, 0.70)
A total of 49 627 of 662 785 ESRD patients received a primary deceased donor transplant.
Chi-square (Race: 2866, 1 df; ESRD Incidence 909, 2 df; Donation Rate: 1769, 2 df).
1Adjusted for patient age, sex, cause of ESRD, incidence year (dialysis, wait-listing), comorbid conditions, employment, BMI and insurance
type.
analyses indicated that ESRD incidence had a profound im-
pact on access to kidney transplantation.
We subsequently evaluated the effect of geographic varia-
tion in organ demand on access to a primary kidney trans-
plant in a covariate-adjusted patient-level analysis (Table 2).
Among the 662 785 new ESRD patients, a total of 150 193
(23%) were placed on the waiting lists for a kidney or
kidney–pancreas transplant and 49 627 (7%) received a
deceased donor kidney transplant by December 31, 2008.
High and moderate donation rates within a DSA led to a 33–
63% higher kidney transplant rate among ESRD patients
compared to low donation areas (medium RR = 1.33, 95%
CI 1.30–1.36; high RR = 1.63, 95% CI 1.60–1.67). High
incidence race was associated with a 44% lower trans-
plant rate versus low incidence race (RR = 0.56, 95% CI
0.55–0.58). While simultaneously adjusting for these fac-
tors and patient characteristics, increasing ESRD incidence
was associated with significantly lower kidney transplant
rates. Compared to low ESRD incidence in the patient’s
DSA, moderate and high ESRD incidence was linked to
significantly lower transplant rates, by 30–32% (medium
RR = 0.70, 95% CI 0.69–0.72; high RR = 0.68, 95%
CI 0.66–0.70). Figure 6 demonstrates the interactions of
ESRD incidence, race and donation rate, and the effect on
transplant rates among ESRD patients. The effect of ESRD
incidence within a DSA was strong; greater incidence was
associated with lower transplant rates regardless of dona-
tion rates or patient race.
The time-to-waiting list registration model among ESRD
patients is displayed in Table 3. Moderate and high do-
nation rates were associated with lower wait-list registra-
tion rates (medium RR = 0.85, 95% CI 0.84–0.86; high
RR = 0.87, 95% CI 0.85–0.88). High ESRD race was as-
sociated with a 31% lower wait-listing rate compared to
low ESRD incidence races (RR = 0.69, 95% CI 0.68–
0.69). Moderate ESRD incidence in the patient’s DSA was
00.100.100.100.100.100.1
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Figure 6: Relative rate ∗∗ of primary
kidney transplant among new ESRD
patients by the ESRD incidence rate
and donation rate of the patient’s
DSA, 2000–2008. This figure demon-
strates the results of a patient-level
analysis evaluating the effect of ESRD
incidence, donation rate and race inci-
dence group on access to kidney trans-
plantation among all ESRD patients.
Stratified by race incidence group, the
effect of medium and high ESRD inci-
dence in the DSA where the patient
was transplanted was associated with
lower transplant rates, regardless of the
patient’s race and DSA-specific dona-
tion rate.
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Table 3: Relative rate1 of wait-listing among ESRD patients, by subgroup, 2000–2008
Measure N % RR1 p-Value 95% CI
OPO-donation rate
Low 226 405 34 1.00 Ref
Medium 241 950 37 0.85 <.0001 (0.84, 0.86)
High 194 430 29 0.87 <.0001 (0.85, 0.88)
All 662 785 100
Race—ESRD incidence
Low 438 342 66 1.00 Ref
High 224 443 34 0.69 <.0001 (0.68, 0.69)
OPO—ESRD incidence
Low 104 745 16 1.00 Ref
Medium 426 746 64 1.02 0.002 (1.01, 1.04)
High 131 294 20 1.02 0.08 (1.00, 1.04)
A total of 150 193 of 662 785 ESRD patients were placed on the waiting list.
Chi-square (Race: 3939, 1df; ESRD Incidence: 10, 2 df; Donation Rate: 710, 2 df).
1Adjusted for patient age, sex, cause of ESRD, incidence year (dialysis, wait-listing), comorbid conditions, employment, BMI and insurance
type.
associated with a 2% higher wait-listing rate compared
to low incidence DSAs, but this trend was not significant
for high ESRD incidence in the patient’s DSA (medium
RR = 1.02, 95% CI 1.01–1.04; high RR = 1.02, 95% CI
1.00–1.04).
Table 4 displays the results of the time-to-kidney trans-
plant model among wait-listed candidates. Transplant rates
increased with increasing donation rates, which was ob-
served in medium and high (58% and 99% greater trans-
plant rates [medium RR = 1.58 and high RR = 1.99],
respectively). High incidence race was associated with
a 14% lower transplant rate (RR = 0.86, 95% CI 0.84–
0.88). After adjusting for patient race, donation rate and
patient characteristics, ESRD incidence was associated
with lower access to kidney transplantation from the wait-
ing list (medium ESRD incidence: 32% lower transplant
rate [RR = 0.68, 95% CI 0.66–0.68]; high ESRD incidence:
37% lower transplant rate [RR = 0.63, 95% CI 0.61–0.65];
ref = low ESRD incidence [RR = 1.00]).
Finally, the correlation between organ demand and or-
gan supply is displayed in Table 5. The density of kid-
ney transplant programs within a DSA was not asso-
ciated with ESRD demand (r = 0.03, p = 0.85). The
percentage of kidney transplants from a living donor
declined significantly with rising ESRD incidence (46–
38% in low to high incidence tertiles), whereas ECD
kidney utilization increased with ESRD incidence (15%
[low]–18% [high]). DSA-specific kidney discard rates in-
creased with higher organ demand, as did the aver-
age kidney DRI. Kidney yield, however, declined with
ESRD incidence. Donor conversion and organ acceptance
rates did not appear to vary significantly with ESRD in-
cidence (r = 0.08, p = 0.57 and r = −0.02, p = 0.89,
respectively).
Table 4: Relative rate1 of transplant among waiting list patients, by subgroup, 2000–2008
Measure N % RR1 p 95% CI
OPO-donation rate
Low 58 551 39 1.00 Ref
Medium 50 946 34 1.58 <.0001 (1.54, 1.61)
High 40 696 27 1.99 <.0001 (1.95, 2.04)
All 150 193 100
Race–ESRD Incidence
Low 105 869 70 1.00 Ref
High 44 324 30 0.86 <.0001 (0.84, 0.88)
OPO – ESRD Incidence
Low 25 647 17 1.00 Ref
Medium 97 981 65 0.68 <.0001 (0.66, 0.69)
High 26 565 18 0.63 <.0001 (0.61, 0.65)
A tatal of 49 627 of 150 193 waitlist patients received a primary deceased donor transplant.
Chi-square (Race: 111, 1df; ESRD Incidence: 1218, 2 df; Donation Rate: 3541, 2 df).
1Adjusted for patient age at wait-listing, race, ethnicity, sex, ESRD cause, wait-listing year, comorbid conditions at wait-listing, insurance
type at wait-listing, blood type, panel reactive antibody (PRA) at wait-listing, employment, BMI and candidate human leukocyte antigens
(HLA).
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Table 5: The correlation between organ supply and organ demand in donation service areas, 2000–20081
ESRD incidence rate DSA ESRD incidence/PMP
United Low Medium High Correlation
States (<300) (300–400) (>400) coefficient (r) p-Value
Number of donation service areas 57 14 31 12
Number of transplant centers per
DSA
4.35 3.86 5.06 3.08 0.03 0.85
Kidneys transplanted from living
donors (%)
39.85 45.77 38.10 38.32 −0.32 0.0145
Kidneys transplanted from
expanded criteria donors (%)
15.93 14.73 15.65 18.21 0.26 0.0489
Kidneys recovered for transplant
but discarded2 (%)
13.87 11.68 13.73 17.06 0.41 0.0016
Kidneys per donor3 (number of KI
txp/number of donors)
1.50 1.59 1.48 1.45 −0.46 0.0004
2008 Standardized donor
conversion rate ratio4
0.99 1.05 0.96 1.02 −0.06 0.63
2008 Organ acceptance rates5
Observed rate 45.7 51.6 43.8 47.3 0.08 0.57
Expected rate 45.8 44.5 46.7 43.6 −0.02 0.89
Average kidney donor risk index6
(standard deviation)
1.13 (0.44) 1.14 (0.41) 1.19 (0.43) 1.24 (0.46) 0.40 0.0022
1Source: Special Analysis, November 2009; SRTR data as of July 2009.
2Organs recovered for transplant and discarded locally or shared and discarded (i.e. donor disposition = 5 and donor reason code 503 or
504).
3Scientific Registry of Transplant Recipients. Guide to the OPO-specific Reports, July 2009. http://www.ustransplant.org/csr/current/Tech_
notes.aspx. Accessed November 16, 2009.
4Ojo AO, Pietroski RE, O’Connor K, McGowan JJ, Dickinson DM. Quantifying organ donation rates by donation service area. Am J
Transplant 2005; 5: 958–966.
5Wolfe RA, LaPorte FB, Rodgers AM, Roys EC, Fant G, Leichtman AB. Developing organ offer and acceptance measures: when good
organs are turned down. Am J Transplant. 2007;7(5 Pt 2):1404–1411.
6Rao PS, Schaubel DE, Guidinger MK, Andreoni KA, Wolfe RA, Merion RM, Port FK, Sung RS. A comprehensive risk quantification score
for deceased donor kidneys: The kidney donor risk index (KDRI). Transplantation 2009; 88: 231–236.
Discussion
We hypothesized that geographic variation in access to
transplantation, measured at the DSA and patient levels,
was a function of organ supply and organ demand. We
found that an increasing concentration of organ donors in
an area augmented access to kidney transplantation. For
patients with ESRD, access to both the waiting list and
to transplant after candidate registration was significantly
diminished in high ESRD areas compared to low ESRD ar-
eas, even after accounting for differences in patient race,
other characteristics and donation rates. Increasing dis-
ease incidence was associated with diminished access to
transplantation at multiple steps in the continuum of care
in kidney disease (22). We further demonstrated that organ
demand in a DSA is correlated with various organ supply
metrics at the DSA level. High ESRD areas were associated
with the utilization of a higher proportion of ECD donors,
higher kidney discard rates and higher kidney DRI.
The OPTN Final Rule states that barriers in access to trans-
plantation such as geography should be removed in order
to provide high quality, equitable care to patients with end-
stage organ failure (23). Several reports have identified
geographic variation in access to kidney and liver trans-
plantation (14,16,17,24–27), but these studies primarily
described patterns of disparities without providing insight
into how this notable variation emerged. Geographic vari-
ation has also been identified in earlier steps in the care of
patients with chronic kidney disease, such as in patterns
of vascular access for dialysis (28). Our study provides a
framework in which to consider how geography affects ac-
cess to care using a plausible mechanism—when scarce
resources are allocated, two things determine access: the
amount of resources available and the number of people
who require those resources. Our analysis represents one
of the first efforts to characterize how patterns of geo-
graphic variation in the incidence of organ failure affect
access to transplant care.
When considered at the DSA or patient level, geography
had a substantial effect on access to kidney transplanta-
tion, which appeared to be mediated to a significant extent
by the incidence of ESRD found in a given area, even af-
ter accounting for local donation rates. We evaluated the
effect of transplant demand on the system as a whole;
the rate of successful kidney transplantation from the to-
tal pool of ESRD patients, and then specifically evaluated
two steps in the kidney transplant process; access to the
waiting list; and access to transplant from the waiting list
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(22). Our findings regarding access to the kidney trans-
plant waiting list raises two important questions related to
the size and significance of the effect of the ESRD inci-
dence. First, while the effect of moderate ESRD incidence
on wait-list rates was statistically significant, the effect size
was small (HR 1.02), and there was no significant effect
observed with high ESRD incidence. This phenomenon
may be related to how providers make decisions about
wait-listing their patients. These decisions are likely driven
more by intrinsic patient factors, such as medical criteria,
quality of life on dialysis and patient and provider percep-
tions of transplant risk and survival benefit, as opposed to
the epidemiology of ESRD in the surrounding area. The im-
pact of ESRD incidence on wait-list rates, however small,
cannot be ignored. High demand for transplant services,
measured by the number of patients on dialysis in a given
area, may lead to congested waiting lists and longer waiting
time. The resources required to provide access to trans-
plant services may be overwhelmed. Transplant providers
may not be able to handle the sheer volume of ESRD pa-
tients served locally, which may lead to variation in trans-
plant center practices, such as early wait-listing (29). In this
context, high ESRD areas may create the perception of
super-saturation, creating a sense of urgency for patients
on dialysis to seek further medical evaluation required to
ultimately improve access to transplant services. The rela-
tionship between local ESRD incidence and access to the
waiting list is complex, and several unmeasured factors are
likely involved in this phenomenon.
The most profound impact of ESRD incidence was on ac-
tual transplant rates. Higher ESRD incidence was associ-
ated with lower transplant rates among all ESRD patients
and the subset on the actual waiting list. Regardless of the
denominator, even moderate ESRD incidence was asso-
ciated with at least a 30% decrease in kidney transplant
rates, and high ESRD incidence was associated with a
32–37% lower transplant rate. This disparity is of signif-
icant clinical concern, because patients who live in rela-
tively ESRD-saturated areas are disadvantaged, and may
be precluded from a potential survival benefit with kidney
transplantation. The most likely reason for this disparity is
related to waiting time. Areas with high ESRD incidence
likely contribute to an extended waiting list course, increas-
ing the time candidates must wait on dialysis, which ulti-
mately increases the likelihood of becoming too sick or dy-
ing before transplant. The current allocation rules attempt
to account for variable waiting time across DSAs by priori-
tizing time on dialysis rather than waiting time specifically
in some areas. If the effect of ESRD incidence is medi-
ated by waiting time, then this policy is substantiated by
our findings. Further, the effect of high ESRD incidence
may lead to lower transplant rates due to super-saturation
of local transplant resources. Patients may not be able
to readily work through their diagnostic testing and other
transplant waiting list evaluation components, leading to
greater inactivation on the waiting list, which makes can-
didates ineligible for transplant. In recent years, increasing
rates of initial Status 7 (inactive status) registrations have
emerged (30–33). In high ESRD areas, this may be pref-
erentially done in order to allow patients to accrue wait-
ing time while they finish their diagnostic evaluation, or to
accommodate the wait-listing of sicker candidates. High
ESRD environments may also be compounded by average
to marginal donation rates, which would further decrease
the transplant rate. Several mechanisms could poten-
tially mediate the effect of ESRD incidence on transplant
rates.
In addition to the independent effect of organ demand on
access to transplant, we demonstrated that various organ
supply-related factors may vary significantly with ESRD
incidence. These relationships further strengthen our con-
ceptual model regarding the effects of organ demand (Fig-
ure 1). High ESRD incidence may induce transplant pro-
grams and OPOs to optimize potential transplant rates in
order to decrease congestion on the waiting list. These
mediating effects may be related to use of more ECD or-
gans, resulting in higher than average DRI in high ESRD
areas. Living donor transplant rates were negatively asso-
ciated with ESRD incidence, which may reflect the current
state of practice patterns in transplant programs, but also
may be related to the potential of less available eligible
living donors in high ESRD areas. With the growing knowl-
edge of the benefits of living kidney transplantation and the
safety of organ donation, this phenomenon may change,
but living donor candidacy may continue to be a problem
in ESRD-rich areas. Organ yield and discard rates declined
with higher ESRD incidence, which may be related to a
greater tendency to procure donor kidneys to increase
access to transplantation, but results in the discard of a
high proportion of inadequate kidneys. These data indicate
that successful kidney transplantation is driven by com-
plex epidemiological phenomena related to the availability
of scarce resources, and how transplant organizations re-
spond to these forces in order to provide the best care for
their patients.
Our analysis also substantiates numerous analyses regard-
ing racial disparities in access to kidney transplantation
by accounting for the effect of geography. We compared
racial groups based on the incidence of ESRD in a specific
population. The high ESRD incident groups, comprised of
African Americans and Native Americans, had relatively
less access to the waiting list and transplantation com-
pared to low incidence ESRD racial groups (whites, Asians
and those of Other/Mixed race), while adjusting for patient-
level factors. These disparities are likely driven by the differ-
ences in access between whites and African Americans,
since they made up the respective majorities in each group.
African American race has been previously associated with
failure to progress through the transplant process (34–37).
The racial differences in access have been attributed to
several factors, including patient preferences and provider
attitudes (9,38–40), and programs have been initiated to in-
crease minority access to transplant (41–43). Our findings
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dovetail with previous studies addressing racial disparities
in access to kidney transplantation.
Our evaluation on how geographical variation in ESRD in-
cidence affects access to transplantation has some limi-
tations. This is an observational study based on registry
data. Due to the methodological design of this study,
causal inferences cannot be made regarding high ESRD
incidence and access to transplantation. Unmeasured fac-
tors, such as socioeconomic status, that affect access
to transplant within a geographic area potentially could
confound our findings. We have also considered disease
incidence over a 9-year period, and practices that poten-
tially affect access to transplant may have had differential
effects within areas of high ESRD incidence. We acknowl-
edge these factors in our conceptual model (Figure 1), and
may include the utilization of extended criteria kidneys, de-
sensitization protocols and living donor kidney transplants.
Center and provider practices in both high and low ESRD
areas may certainly contribute to the patterns in access
noted in our study, particularly with regards to competi-
tion, which we have established has detrimental effects on
relative kidney transplant rates (17). This study also does
not account for individual medical decision-making, which
accounts for patient preferences and clinical factors not
necessarily captured in our data. Despite these limitations,
our study represents one of the only attempts to charac-
terize the mechanism of geographic variation in access to
transplantation.
The fact that the rate of endemic ESRD influences ac-
cess to transplantation for two otherwise similar ESRD
patients living in different areas has significant policy im-
plications. In the context of the Final Rule, this inequity
should potentially be addressed in the policies governing
the allocation of kidneys. The current kidney allocation sys-
tem is under review by the OPTN and the transplant com-
munity, and future allocation paradigms should address
geographic inequities more broadly. Increased organ shar-
ing with high ESRD areas could have a tremendous im-
pact on improving equity without necessarily diminishing
the utility of the donated organ. With a 2% higher wait-
listing rate in high ESRD areas and a 37% lower trans-
plant rate from the waiting list in these areas compared
to low ESRD areas, it is clear that geographic disparities
are problematic in a very tangible way, and that policies
that include rules to help remove this inequity should be
encouraged. We have also demonstrated that high organ
supply, in addition to organ demand, is associated with
higher wait-listing and transplant rates. The effective organ
supply in a given area may be driven by a variety of fac-
tors that are determined by OPO and transplant program
behavior. Increasing utilization of ECD kidneys, aggres-
sive organ acceptance practices and competition between
transplant programs may affect transplant rates. We have
previously evaluated how competition affects kidney trans-
plant rates, and have shown that more competition actually
resulted in lower, rather than higher, transplant rates (17).
Policies to increase the effective organ supply that focus
on transplant program and OPO performance may result
in greater access to kidney transplantation, and may over-
come the barriers related to geographic variation in organ
demand.
In summary, high ESRD incidence in a given geographic
area is associated with lower access to transplant, regard-
less of race/ethnicity. Racial/ethnic disparities in access to
the kidney waiting list and to transplant for wait-listed can-
didates were notable, even after accounting for differences
in donation rates and ESRD incidence. These findings fur-
ther elucidate the mechanisms of geographic disparities in
access to transplantation, and policy makers should con-
sider these disparities in allocation policy reform.
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